Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
Vivos Therapeutics, Inc., a medical device company specializing in innovative treatments for obstructive sleep apnea (OSA), announced it will release its second quarter 2026 financial results on August 14, 2026, followed by a conference call to discuss operational updates and strategic collaborations aimed at near-term revenue growth and cash burn …